USAID Awards Science And Technology Pioneers Prize To South African HIV Trial

SAnews.gov.za: South African HIV/AIDS trial scoops USAID award
“The Centre for the AIDS Programme of Research in South Africa (CAPRISA) 004 Tenofovir gel trial was … announced as the winner of the United States Agency for International Development (USAID) Science and Technology Pioneers Prize. … The CAPRISA 004 Tenofovir gel trial, conducted in KwaZulu-Natal, was funded by USAID and the South African Department of Science and Technology, and conducted by a group of South African and U.S. researchers. It provided proof of concept that an antiretroviral gel used before and after sex can protect women against HIV…” (1/29).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.